Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1990-3-28
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0047-1852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48 Suppl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
233-5
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:2621875-Fructose-Bisphosphate Aldolase,
pubmed-meshheading:2621875-Hematologic Diseases,
pubmed-meshheading:2621875-Humans,
pubmed-meshheading:2621875-Isoenzymes,
pubmed-meshheading:2621875-Muscular Dystrophies,
pubmed-meshheading:2621875-Myocardial Infarction,
pubmed-meshheading:2621875-Neoplasms,
pubmed-meshheading:2621875-Reference Values,
pubmed-meshheading:2621875-Tissue Distribution
|
pubmed:year |
1989
|
pubmed:articleTitle |
[Clinical significance of aldolase analysis in biochemical laboratory tests].
|
pubmed:publicationType |
Journal Article
|